• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Balancing new with common recruitment tactics

Balancing new with common recruitment tactics

December 1, 2017
CenterWatch Staff

For sponsors and CROs, patient recruit­ment has become a moving target. Re­cruitment tactics are shifting from the use of traditional, centralized advertising to digital and online media. Outreach strate­gies have become more targeted and com­panies are moving toward leveraging net­works of electronic medical records (EMRs) and other data to support more effective recruitment for clinical trials. Yet there are mixed opinions about the value of digital or social media campaigns. While drug development executives ex­pect EMRs and health records to play a major role in patient recruitment within five years, according to the Tufts Center for the Study of Drug Development (CSDD), much of the data needed to identify eligi­ble clinical trial participants doesn’t exist in EMRs. The systems weren’t designed for simplifying searches across files.

 Survey shows companies aim to increase range of patient data in clinical trials

 Most life sciences companies plan to significantly step up their use of real-world data sources over the next three years, according to a new survey by the Tufts Center for the Study of Drug Development. In the second report from the 2017 eClin­ical Landscape Study, one of the largest, most in-depth surveys of clinical data man­agement professionals, 97% of companies polled said they plan to increase their use of at least one source of clinical data to im­prove the accuracy of their decisions in the development process.

 

To read the full articles for this issue of The CenterWatch Monthly, please click here for subscription information.

 

Upcoming Events

  • 16Feb

    Fundamentals of FDA Inspection Management: Reduce Anxiety, Increase Inspection Success

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • SurveywBlueBackground-360x240.png

    Sites Name Tech Acceptance as Essential Factor in Selection of Sponsors, Survey Finds

  • TrendsInsights2023-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Two

  • TimeMoneyEffort-360x240.png

    Time is Money and So Is Effort, Budgeting Experts Say

  • TrendsInsights2023A-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Three

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing